ClinicalTrials.Veeva

Menu

Aortic Valve Replacement for Moderate Aortic Stenosis With Left Ventricular Decompensation Early Feasibility Study

D

Dermed Diagnostics, Inc.

Status

Withdrawn

Conditions

Moderate Aortic Valve Stenosis

Treatments

Procedure: Ross procedure

Study type

Interventional

Funder types

Industry

Identifiers

NCT07060183
Moderate Aortic Stenosis AVR

Details and patient eligibility

About

Obtain safety and effectiveness data to support expansion for aortic valve replacement to include patients with moderate aortic stenosis and left ventricular decompensation.

Full description

Single-center prospective study. Subjects with moderate aortic stenosis and left ventricular decompensation will receive aortic valve replacement by the Ross procedure.

Sex

All

Ages

55 to 79 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Moderate aortic stenosis, defined by transthoracic echocardiograph
  • Max aortic velocity less than 4.0 m/sec.
  • Mean aortic gradient less than 40.0 mmHg.
  • 1.0 cm2 < Aortic Valve Area < 1.5 cm2.
  • Left ventricular decompensation

Exclusion criteria

  • Not suitable for the Ross procedure.
  • Documented history of cardiac amyloidosis.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

0 participants in 2 patient groups

Intervention
Experimental group
Description:
Aortic Valve Replacement
Treatment:
Procedure: Ross procedure
Control
No Intervention group
Description:
No intervention

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems